Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hirotsugu Komatsu, Takeshi Tanaka, Zhengmao Ye, Ken Ikeda, Takao Matsuzaki, Mayo Yasugi & Masato Hosoda. (2023) Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction system. Journal of Biomolecular Structure and Dynamics 41:5, pages 1767-1775.
Read now
Read now
Soham Mukherjee, Deepika Sharma, Ajay Kumar Sharma, Shreya Jaiswal, Nancy Sharma, Sangkha Borah & Gurjot Kaur. (2022) Flavan-based phytoconstituents inhibit Mpro, a SARS-COV-2 molecular target, in silico. Journal of Biomolecular Structure and Dynamics 40:22, pages 11545-11559.
Read now
Read now
Armin Zarei, Ali Ramazani, Saeed Pourmand, Ahmad Sattari, Aram Rezaei & Sajad Moradi. (2022) In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds. Natural Product Research 36:16, pages 4254-4260.
Read now
Read now
Articles from other publishers (24)
Rajib Majumder, Sanmitra Ghosh, Manoj K. Singh, Arpita Das, Swagata Roy Chowdhury, Abinit Saha & Rudra P. Saha. (2023) Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs. COVID 3:4, pages 494-519.
Crossref
Crossref
Abdus Samad, Amar Ajmal, Arif Mahmood, Beenish Khurshid, Ping Li, Syed Mansoor Jan, Ashfaq Ur Rehman, Pei He, Ashraf N. Abdalla, Muhammad Umair, Junjian Hu & Abdul Wadood. (2023) Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Dylan Brunt, Phillip M. Lakernick & Chun Wu. (2022) Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations. Scientific Reports 12:1.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Sakshi Piplani, Puneet Singh, David A. Winkler & Nikolai Petrovsky. (2022) Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase. International Journal of Molecular Sciences 23:14, pages 7704.
Crossref
Crossref
Bárbara Longhini Gonzalez, Natalia Castelhano de Oliveira, Mariane Roberta Ritter, Fernanda Stumpf Tonin, Eduardo Borges Melo, Andréia Cristina Conegero Sanches, Fernando Fernandez‐Llimos, Marcus Vinícius Petruco, João Carlos Palazzo de Mello, Danielly Chierrito & Daniela Cristina de Medeiros Araújo. (2022)
The naturally‐derived alkaloids as a potential treatment for
COVID
‐19: A scoping review
. Phytotherapy Research 36:7, pages 2686-2709.
Crossref
Crossref
Mohamed Fadlalla, Mazin Ahmed, Musab Ali, Abdulrhman A. Elshiekh & Bashir A. Yousef. (2022) Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models. Current Pharmacology Reports 8:3, pages 212-226.
Crossref
Crossref
Katlyn Nemani, Sharifa Z. Williams, Mark Olfson, Emily Leckman-Westin, Molly Finnerty, Jammie Kammer, Thomas E. Smith, Daniel J. Silverman, Jean-Pierre Lindenmayer, Gillian Capichioni, James Clelland & Donald C. Goff. (2022) Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System. JAMA Network Open 5:5, pages e2210743.
Crossref
Crossref
Sakshi Piplani, Puneet Singh, Nikolai Petrovsky & David A. Winkler. (2022) Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Neetu Agrawal & Ahsas Goyal. (2022) Potential Candidates against COVID-19 Targeting RNA-Dependent RNA
Polymerase: A Comprehensive Review. Current Pharmaceutical Biotechnology 23:3, pages 396-419.
Crossref
Crossref
Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li & Hai-Liang Zhu. (2022) Promising Enzymes for Inhibitors Development Against COVID-19. Mini-Reviews in Medicinal Chemistry 22:3, pages 449-456.
Crossref
Crossref
Ali Fallah, Hadi Razavi Nikoo, Hamidreza Abbasi, Azadeh Mohammad-Hasani, Abasalt Hosseinzadeh Colagar & Ayyoob Khosravi. (2022) Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 2019. Intervirology 65:3, pages 119-133.
Crossref
Crossref
Jahangir Emrani, Maryam Ahmed, Liesl Jeffers-Francis, John C. Teleha, Nathan Mowa, Robert H. Newman & Misty D. Thomas. (2021) SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review. International Journal of Biological Macromolecules 193, pages 1249-1273.
Crossref
Crossref
Qi Liao, Ziyu Chen, Yanlin Tao, Beibei Zhang, Xiaojun Wu, Li Yang, Qingzhong Wang & Zhengtao Wang. (2021) An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro. Scientific Reports 11:1.
Crossref
Crossref
Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar & Brijesh Rathi. (2021) Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. RSC Advances 11:57, pages 36181-36198.
Crossref
Crossref
Merve Yuce, Erdem Cicek, Tugce Inan, Aslihan Basak Dag, Ozge Kurkcuoglu & Fethiye Aylin Sungur. (2021)
Repurposing of
FDA
‐approved drugs against active site and potential allosteric drug‐binding sites of
COVID
‐19 main protease
. Proteins: Structure, Function, and Bioinformatics 89:11, pages 1425-1441.
Crossref
Crossref
Hope Onohuean, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari & Gaber El-Saber Batiha. (2021) Covid-19 and development of heart failure: mystery and truth. Naunyn-Schmiedeberg's Archives of Pharmacology 394:10, pages 2013-2021.
Crossref
Crossref
Somayye Taghvaei, Farzaneh Sabouni & Zarrin Minuchehr. (2021) Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort. Frontiers in Pharmacology 12.
Crossref
Crossref
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, Maryam Naseri, Mohammad Hosein Farzaei & Javier Echeverría. (2021) Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-21.
Crossref
Crossref
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, Gihwan Lee & Keun Woo Lee. (2021) Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Vikas Kumar & Mohammad A. Kamal. (2021) The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19. Current Pharmaceutical Design 27:9, pages 1202-1210.
Crossref
Crossref
Vaibhav Tripathi, Deepak Kumar Dash, Neelesh Chaubey, Anil Kumar Sahu & Lalit Pal. (2021) Repurposed application of doxycycline in COVID 19 treatment. International Journal of Pharmaceutical Chemistry and Analysis 7:4, pages 151-154.
Crossref
Crossref
Vinay Kumar & Kunal Roy. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
541
578
.
Xia Xiao, Conghui Wang, De Chang, Ying Wang, Xiaojing Dong, Tao Jiao, Zhendong Zhao, Lili Ren, Charles S. Dela Cruz, Lokesh Sharma, Xiaobo Lei & Jianwei Wang. (2020) Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Frontiers in Immunology 11.
Crossref
Crossref